PubRank

Linda H Malkas

Author PubWeight™ 29.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 2008 1.96
2 Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res 2004 1.33
3 DNA damage-induced phosphorylation of the human telomere-associated protein TRF2. Proc Natl Acad Sci U S A 2005 1.24
4 The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics 2006 1.12
5 Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Mol Pharmacol 2012 1.02
6 DNMT1 is a component of a multiprotein DNA replication complex. Cell Cycle 2003 0.96
7 Human cell DNA replication is mediated by a discrete multiprotein complex. J Cell Biochem 2002 0.95
8 Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids. Pediatr Surg Int 2008 0.88
9 Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg 2006 0.86
10 Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers. J Surg Res 2007 0.86
11 Isolation and characterization of a DNA synthesome from a neuroblastoma cell line. J Pediatr Surg 2005 0.84
12 Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer. Prostate 2010 0.84
13 Applications of emerging molecular technologies in glioblastoma multiforme. Expert Rev Neurother 2008 0.83
14 Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126. J Pediatr Surg 2006 0.82
15 Diagnosis of esophageal adenocarcinoma by serum proteomic pattern. Ann Thorac Surg 2007 0.81
16 Nuclear protein isoforms: implications for cancer diagnosis and therapy. J Cell Biochem 2011 0.81
17 Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma. Pediatr Blood Cancer 2009 0.81
18 A novel biomarker for the detection of esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2006 0.80
19 Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. Bioorg Med Chem 2002 0.80
20 Characterization of RNA primers synthesized by the human breast cancer cell DNA synthesome. J Cell Biochem 2009 0.79
21 The DNA synthesome: its potential as a novel in vitro model system for studying S-phase specific anticancer agents. Crit Rev Oncol Hematol 2003 0.79
22 Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints. J Pediatr Surg 2005 0.79
23 Structural analysis of the human neuroblastoma DNA replication complex: insights into faulty proliferation. J Pediatr Surg 2006 0.79
24 Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling. J Surg Res 2006 0.79
25 Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance. Cancer Chemother Pharmacol 2014 0.79
26 Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome. Toxicol Appl Pharmacol 2009 0.79
27 Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration. Front Oncol 2013 0.79
28 Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer? J Pediatr Surg 2006 0.79
29 An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents. Biochem Pharmacol 2004 0.78
30 Oxidative status in neuroblastoma: a source of stress? J Pediatr Surg 2008 0.77
31 Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Mol Sci 2012 0.77
32 Error-promoting DNA synthesis in ovarian cancer cells. Gynecol Oncol 2013 0.75
33 Proteomic analysis of neuroblastoma microenvironment: effect of the host-tumor interaction on disease progression. J Surg Res 2009 0.75
34 Proteomic approaches in neuroblastoma: a complementary clinical platform for the future. Expert Rev Proteomics 2009 0.75
35 How does the Proliferating Cell Nuclear Antigen modulate binding specificity to multiple partner proteins? J Chem Inf Model 2017 0.75